{"record":{"code":"W-01090","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"SNY · SUB · BR · DISTRITO FEDERAL SECRETARIA DE SAUDE","buyer":"","amount":1238311.5768,"currency":null,"records":1,"found":"2026-10-04","refs":["ocds-914jxj-92611907000092025","2018-09-04"],"id":"W-01090","html":"https://worldwide-corruption.com/record/brazil/findings/fcpa-pattern/W-01090/","json":"https://worldwide-corruption.com/record/brazil/findings/fcpa-pattern/W-01090/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «SANOFI MEDLEY FARMACEUTICA LTDA» ↔ SEC SNY (CIK 1121404, Sanofi): 1 non-competitive contracts at the buyer «DISTRITO FEDERAL SECRETARIA DE SAUDE», 6,879,509 BRL (≈ $1,238,312); method direct (tipoInstrumentoConvocatorioCodigo: 3; tipoInstrumentoConvocatorioNome: Ato que autoriza a Contratação Direta; modoDisputaId: 5; modoDisputaNome: Não se aplica; srp: false); OCID ocds-914jxj-92611907000092025; ⚑ REPEAT: already sanctioned SEC by FCPA (2018-09-04 Sanofi); ↓ weak method (catalogue / exclusivity / accreditation / small purchase); class B: direct method prescribed by law (loan, lease, inter-agency) or pandemic emergency purchase.","facts":[["Company / subject","SNY · SUB · BR · DISTRITO FEDERAL SECRETARIA DE SAUDE",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","1,238,312",null],["Records behind the indicator","1",null],["Found","4 October 2026",null],["Code","W-01090",null],["Reference","ocds-914jxj-92611907000092025",null],["Reference","2018-09-04",null]],"summary":"subsidiary/issuer «SANOFI MEDLEY FARMACEUTICA LTDA» ↔ SEC SNY (CIK 1121404, Sanofi): 1 non-competitive contracts at the buyer «DISTRITO FEDERAL SECRETARIA DE SAUDE», 6,879,509 BRL (≈ $1,238,312); method direct (tipoInstrumentoConvocatorioCodigo: 3; tipoInstrumentoConvocatorioNome: Ato que autoriza a Contratação Direta; modoDisputaId: 5; modoDisputaNome: Não se aplica; srp: false); OCID ocds-914jxj-92611907000092025; ⚑ REPEAT: already sanctioned SEC by FCPA (2018-09-04 Sanofi); ↓ weak method (catalogue / exclusivity / accreditation / small purchase); class B: direct method prescribed by law (loan, lease, inter-agency) or pandemic emergency purchase","entity":"8471d035"},"about":"Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.","evidence":[],"row":{"country":"Brazil","iso2":"BR","part":"Findings","indicator":"Debarred / sanctioned abroad × US SEC issuer","about":"Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.","findings":1312,"new_today":0,"on_pages":1312,"full_list":[],"html":"https://worldwide-corruption.com/database/brazil/findings/fcpa-pattern/","json":"https://worldwide-corruption.com/database/brazil/findings/fcpa-pattern/index.json"},"other_records_of_this_company":[],"html":"https://worldwide-corruption.com/record/brazil/findings/fcpa-pattern/W-01090/","json":"https://worldwide-corruption.com/record/brazil/findings/fcpa-pattern/W-01090/index.json"}